NPPB and heart failure: The analysis of the data obtained from the study showed that both BNP and NTproBNP can be used in the diagnosis of heart failure with left ventricular systolic dysfunction with a sensitivity of only 76%, so one in four patients would remain undiagnosed based on these biomarkers alone [55].